mass spectrometry raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-04-18. Anything still debated is marked as such rather than presented as settled.
Reported activity for Selank centers on anxiolytic and nootropic effects. Russian clinical reports describe use in anxiety and in cognitive or attention-related complaints. Most of this evidence comes from studies conducted by the same research groups that developed the peptide. Independent replication in other countries remains limited, and no major Western regulatory agency has approved the compound for any indication. The gap between local reports and external verification is a recurring point in discussions of the peptide.
Tuftsin, the parent structure, is a naturally occurring immunomodulatory tetrapeptide released from the Fc region of immunoglobulin G by spleen enzymes. Selank extends this four-residue sequence with three additional amino acids. The stated rationale is that the added tail slows enzymatic breakdown and may influence receptor interactions. How the full heptapeptide behaves at the molecular level is not firmly established, and proposed mechanisms often involve indirect modulation of neurotransmitter or immune signaling rather than a single defined target.
Selank is a synthetic heptapeptide developed in Russia. Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, a seven-residue chain built around the natural tetrapeptide tuftsin. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences first described the compound in the mid-1990s. The design combined the tuftsin core with an added Pro-Gly-Pro tail, a modification intended to extend the molecule's stability in biological fluids. Published work on the peptide has appeared mainly in Russian-language journals.
Characterization of Selank in laboratory settings relies on standard peptide analytical techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and degradation products, while mass spectrometry confirms molecular identity through accurate mass measurement. Amino acid analysis and peptide sequencing verify the primary structure when reference material is unavailable. Because Selank is a short chain, fragmentation-based analysis produces a diagnostic ion pattern that supports confident identification.
Peptide stability depends strongly on temperature, moisture, and pH. Lyophilized Selank is generally most stable when stored cold and dry, with freezer temperatures commonly used for long-term storage. In solution, the compound is susceptible to hydrolysis and to microbial growth if it is not handled aseptically. The C-terminal proline-rich extension appears to slow enzymatic cleavage relative to tuftsin, though quantitative degradation rates vary with the matrix and the conditions tested. Published stability data specific to Selank remain sparse.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic heptapeptide | Modeled on tuftsin |
| Amino acid sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Seven residues |
| Approximate molecular mass | Around 750 Da | Depends on counter-ion and hydration |
| Common forms | Lyophilized powder | Also described as aqueous solution |
| Primary origin of research | Russian laboratories | Mid-1990s onward |
Lyophilized Selank, the dry powder form, is generally stored frozen at minus 20 degrees Celsius or colder for long-term keeping. The solid is hygroscopic and should stay sealed, dry, and protected from light. Once dissolved, the peptide is less stable and is usually held refrigerated at 2 to 8 degrees Celsius for short periods. Repeated freezing and thawing is avoided because it can promote aggregation and loss of activity. Buffers and pH choice also affect how long a solution remains usable.
Solubility behavior is a practical concern for handling. Selank dissolves readily in water and in common aqueous buffers, which simplifies preparation of working solutions. The choice of solvent, ionic strength, and pH can influence aggregation over time, particularly at higher concentrations. Aqueous solutions are typically sterile-filtered before use. Because stability depends on several variables, storage and handling notes should be treated as general guidance rather than fixed rules, and specific values are best confirmed against a certificate of analysis for each batch.
Characterization of Selank in a laboratory setting relies on standard peptide methods. Reverse-phase high-performance liquid chromatography separates the target from related impurities and provides a purity figure, commonly reported as 95 percent or higher. Mass spectrometry, typically electrospray ionization or matrix-assisted laser desorption, confirms the molecular mass and helps detect truncation or modification. Amino acid analysis can verify composition when a sequence-level check is needed. These techniques together establish identity and purity for a given lot.
Selank is a synthetic heptapeptide developed in Russia as a structural analogue of tuftsin, a naturally occurring immunomodulatory tetrapeptide. Its sequence, Thr-Lys-Pro-Arg-Pro-Gly-Pro, keeps the tuftsin core at the N-terminus and appends a Pro-Gly-Pro tail. Researchers at the Institute of Molecular Genetics in Moscow synthesized the compound during the 1990s while searching for peptides with combined anxiolytic and immunomodulatory activity. The added tail was intended to resist enzymatic cleavage and prolong the molecule's presence in circulation.
The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.
Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.
Reverse-phase high-performance liquid chromatography with ultraviolet detection near 214 nanometres is the standard purity method. Mass spectrometry, typically electrospray ionisation, confirms identity through the expected mass-to-charge pattern. Amino acid analysis can verify composition independently. Chiral purity requires separate techniques such as derivatisation followed by chromatographic separation, and such data are rarely reported for research-grade material.
Quantification in biological matrices relies on liquid chromatography coupled to tandem mass spectrometry with stable-isotope internal standards. Low plasma concentrations and adsorption to container surfaces both complicate measurement. Solid-phase extraction is often needed to reduce matrix interference before injection. Reported limits of quantification differ widely between laboratories, which makes direct comparison of pharmacokinetic results difficult and limits meta-analysis.
Peptide bonds are vulnerable to protease attack, and Selank is no exception. Measured half-life in serum is short, on the order of minutes in several reports, which explains why intranasal administration is the common route described in the literature. Absorption across the nasal mucosa partially bypasses first-pass hepatic metabolism. Quantitative data on human bioavailability remain limited and are difficult to compare across studies.
Selank is studied chiefly as an animal-model anxiolytic with proposed secondary effects on memory and immune signaling. Reported mechanisms include modulation of the GABA-A receptor complex, inhibition of enkephalin-degrading enzymes, and shifts in monoamine turnover within limbic structures. Some experiments describe increased expression of brain-derived neurotrophic factor in the hippocampus after repeated dosing. No single molecular target has been confirmed, and the peptide does not bind any receptor with the selectivity typical of a conventional small-molecule drug. Mechanism therefore remains a set of hypotheses rather than an established pathway.
Laboratory work relies on standard behavioral paradigms. Rodents are tested in the elevated plus maze, open field, and passive avoidance tasks, with outcomes compared against diazepam or vehicle controls. Intranasal dosing is used most often because it bypasses first-pass metabolism, though intraperitoneal and intravenous routes also appear in published protocols. Biochemical endpoints include tissue BDNF concentrations, cytokine levels, and monoamine metabolites. Human data are limited to small Russian trials reporting reduced anxiety scores; most were not prospectively registered, and few employed independent outcome assessment.
Despite its feathers, palaeontologists do not consider Sinosauropteryx to be a bird. Phylogenetically, the genus is only distantly related to the clade Aves, usually defined as Archaeopteryx lithographica plus modern birds. The scientists who described Sinosauropteryx, however, used a character-based, or apomorphic, definition of the Class Aves, in which any animal with feathers is considered to be a bird. They argued that the filamentous plumes of Sinosauropteryx represent true feathers with a rachis and barbs, and thus that Sinosauropteryx should be considered a true bird. They classified the genus as belonging to a new biological order, Sinosauropterygiformes, family Sinosauropterygidae, within the subclass Sauriurae. These proposals have not been accepted, and Sinosauropteryx is generally classified in the family Compsognathidae, a group of small-bodied long-tailed coelurosaurian theropods known from the Late Jurassic and Early Cretaceous of Asia, Europe, and South America. Below is a cladogram showing the placement of Sinosauropteryx within Coelurosauria by Senter et al. in 2012.
In 2007, she appeared opposite Milla Jovovich in Resident Evil: Extinction, portraying Claire Redfield, who in the film, is the leader of a convoy of zombie apocalypse survivors going to Alaska in search of a safe haven. Her role sent her to Mexicali, Mexico for filming from May to late July, and required her hair to be dyed a light red. Speaking about her character Claire, Larter said, "She became the leader of this convoy. She's incredibly strong, patient. I think she serves a role for everyone within this convoy, let it be a mother to someone, a buddy, a best friend." Despite negative reviews, the film made $147 million worldwide. Also in the same year, she appeared with Hayes MacArthur in the comedy Homo Erectus and appeared as Evelyn Garland in the biographical drama Crazy, based on guitarist Hank Garland. Larter starred opposite Beyoncé and Idris Elba from London, in the Screen Gems-produced thriller Obsessed (2009). The film follows an office executive Derek Charles (Elba) whose marriage to Knowles' character Sharon is threatened by the aggressive interests of a co-worker Lisa Sheridan, portrayed by Larter. In an interview with Glam, Larter said that she "was excited to get the chance to play a femme fatale. I love playing women that are dark and vulnerable and sort of filled with a little bit of crazy emotion." While the film was released to mixed reviews, Larter was critically praised for her performance.
== External links == Collagen+type+III at the U.S. National Library of Medicine Medical Subject Headings (MeSH) "COL3A1". Ehlers Danlos Syndrome Variant Database. Archived from the original on 2021-01-26. Retrieved 2018-12-05. "Report for CCDS2297.1". Consensus Coding Sequence (CDS) Database. National Center for Biotechnology Information (NCBI).
Sources: en.wikipedia.org
21 May – IBM announces that it will begin development of a 100,000-qubit quantum computer, the world's largest and most powerful, to be completed by 2033. 22 May – A study quantifies "the human cost of global warming", showing current policies "leading to around 2.7 °C global warming could by 2080–2100 leave one-third (22–39%)" of people outside their climate niche (see also 4 May 2020) – humans' long-time range of mean annual temperatures to which their physiology may have largely adapted to. It indicates meeting the 1.5 °C goal would decrease the population exposed to unprecedented heat ~5-fold and ties itself to earlier research by initially noting that quantifying the social cost of carbon in monetary terms, as related or economics studies tend to do, may be inadequate. 23 May Using the Hubble Space Telescope and Gaia spacecraft, an analysis of proper motions of the closest known globular cluster, Messier 4, reveals an excess mass of roughly 800 solar masses in the center. This appears to not be extended, and could thus be the best kinematic evidence for an intermediate-mass black hole (even if an unusually compact cluster of compact objects, white dwarfs, neutron stars or stellar-mass black holes cannot be completely discounted). A study identifies plastic chopping boards as a substantial source of ingested microplastics. Researchers show plastic recycling facilities are a major source of microplastic water pollution (1 May).
Concerns regarding the sustainability of Chinese-financed projects, environmental impacts, and the lack of transparency in their investments call for a careful assessment of these collaborations. Iranian President Mahmoud Ahmadinejad met with Mahama in 2013 to hold discussions on strengthening the Non-Aligned Movement and also co–chair a bilateral meeting between Ghana and Iran at the Ghanaian presidential palace Flagstaff House. The Sustainable Development Goals (SDG) were integrated into Ghana's development agenda and the budget. According to reports, the SDGs were implemented through a decentralized planning approach. This allows for stakeholders' participation, such as in UN agencies, traditional leaders, civil society organizations, academia, and others. The 17 SDGs are a global call to action to end poverty among others, and the UN and its partners in the country are working towards achieving them. According to the President Nana Akufo-Addo, Ghana was "the first Sub-Saharan African country to achieve the goal of halving poverty, as contained in Goal 1 of the Millennium Development Goals".
On the basis of the data available, the Panel concludes that a cause-and-effect relationship has been established between the consumption of beta-glucans and the "reduction of blood cholesterol concentrations." The following wording reflects the scientific evidence: "Regular consumption of beta-glucans contributes to maintenance of normal blood cholesterol concentrations." In order to bear the claim, foods should provide at least 3 g/d of beta-glucans from oats, oat bran, barley, barley bran, or mixtures of non-processed or minimally processed beta-glucans in one or more servings. The target population is adults with normal or mildly elevated blood cholesterol concentrations. In November 2011, the EU Commission published its decision in favour of oat beta-glucans with regard to Article 14 of the EC Regulation on the labelling of foodstuffs with nutrition and health claim statements permitting oat beta-glucan to be described as beneficial to health. Following the opinion of the Panel on Dietetic Products, Nutrition and Allergies (NDA) the EFSA and the Regulation (EU) no. 1160/2011 of the Commission, foodstuffs through which 3 g/day of oat beta-glucan are consumed (1 g of oat beta-glucan per portion) are allowed to display the following health claim: "Oat beta-glucan reduces the cholesterol level in the blood.
=== 2021 === By January 2021, North Korea's borders had been closed for one year. According to South Korean analysis, trade between North Korea and China had fallen by 76%. In March, North Korea decided not to participate in the 2020 Summer Olympics in Tokyo due to concerns over potential exposure to COVID-19. As a result, the Olympic Committee of the Democratic People's Republic of Korea was suspended by the International Olympic Committee (IOC) through the end of 2022, thus prohibiting the country from participating in the 2022 Winter Olympics in Beijing. In April 2021, Russian diplomats in Pyongyang said that North Korea had "total restrictions that are unprecedented in their severity", as well as severe shortages. According to the diplomatic mission, many foreign diplomats had left the country, leaving less than 290 foreigners in North Korea, including only nine ambassadors and four chargés d'affaires. Later that month, Kim Jong Un said North Korea was facing its "worst-ever situation" in reference to the economic downturn due to COVID-19; he called for the party to wage another Arduous March to fight the severe economic difficulties. However, the translation as "worst-ever situation" has been disputed by some analysts as an exaggeration, with the original speech (극난한) translatable as simply a very hard, or difficult situation. The translation as "worst-ever" had also been previously used in the 8th Congress of the Workers' Party of Korea to refer to the past five years, yet the economy is in nowhere near as much difficulty as in the 1990s.
Sources: en.wikipedia.org
Selank is a synthetic peptide made of seven amino acids. It is modeled on tuftsin, a natural tetrapeptide, with an added three-residue tail. It is not a small-molecule drug.
It originates from research in Russia, associated with the Institute of Molecular Genetics of the Russian Academy of Sciences. The first descriptions date to the mid-1990s. Most published studies come from Russian laboratories.
No, Selank itself does not occur naturally. Its backbone is based on tuftsin, which is produced in the body, but the seven-residue version is a synthetic construct. It is supplied as a manufactured peptide.
The most common approach combines reverse-phase liquid chromatography with mass spectrometry. Chromatography separates the components while mass spectrometry confirms the molecular mass. Peptide sequencing or tandem mass analysis can further verify the amino acid order.